R, C., M, G., M, H., MÀ, S., C, L., P, R., . . . A, O. (2026). Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: Relationship between cefiderocol minimum inhibitory concentration and clinical outcomes. The Journal of antimicrobial chemotherapy, 81(6), . https://doi.org/10.1093/jac/dkag164
Chicago Style (17th ed.) CitationR, Cantón, García-Castillo M, Hernández-García M, Sastre-Femenía MÀ, López-Causapé C, Ruiz-Garbajosa P, García Labrador L, Longshaw C, and Oliver A. "Cefiderocol Activity Against Multidrug-resistant Isolates from the PERSEUS Study: Relationship Between Cefiderocol Minimum Inhibitory Concentration and Clinical Outcomes." The Journal of Antimicrobial Chemotherapy 81, no. 6 (2026). https://doi.org/10.1093/jac/dkag164.
MLA (9th ed.) CitationR, Cantón, et al. "Cefiderocol Activity Against Multidrug-resistant Isolates from the PERSEUS Study: Relationship Between Cefiderocol Minimum Inhibitory Concentration and Clinical Outcomes." The Journal of Antimicrobial Chemotherapy, vol. 81, no. 6, 2026, https://doi.org/10.1093/jac/dkag164.